Austin, TX 10/24/2007 9:49:30 PM
Speak with other shareholders about: (OTC BB: EFCR), (OTC BB: BSLM) and (Pink Sheet: RBRM)
Are you looking to speak with other investors about your favorite stock? Stockwire.com, ranked in the top 5,000 websites in the United States by Alexa.com/Amazon.com, has created one of the finest chat programs available for investors. Now you can chat real-time with like-minded individuals about your favorite stock. Visit Stockwire.com and click the “Chat Live” button at the top.
----------------------------------------------------------
Chat real-time with other investors about this EFCR news release, by
clicking this link: http://www.stockwire.com/EFCR
To view in-depth research, click the following link:
http://www.stockwire.com/detailed/analysis.php?company=EFCR
EGPI Firecreek Inc (OTC BB: EFCR)
EGPI/Firecreek, Inc. Signs MOU with Success Oil Co. for Majority Interests in West Texas Oil Program (Deal to Acquire 75% Working Interests J.B. Tubb/AMOCO Crawar Property North 40 Acre Initial Two Well Reentry Program)
SCOTTSDALE, Ariz., Oct 24, 2007 EGPI/Firecreek, Inc. and its wholly owned subsidiary, Firecreek Petroleum, Inc. announced today that it has signed an MOU to acquire 75% working interest in Success Oil Co's J.B. Tubb/Amoco Crawar Property, North 40 Acres. This includes an initial two well reentry program for oil and gas.
The J.B. Tubb/Amoco Crawar oil and gas property is located in the Permian Basin, Crawar Field in Ward County, West Texas (12 miles west of Monahans & 30 miles west of Odessa).
The proposed acquisition and corresponding work program includes reentry into two wells in the Upper Clearfork formation (from 4200-4400 feet), and Lower Clearfork formation (from 4550-4750 feet) for the production of oil and gas.
This property is located in and is a part of the Crawar Field, already considered one of the most prolific fields in the United States. Several major oil companies already have projects in this large field. Total present Crawar field statistics show overall production of 500,000 barrels of oil and 4.6 BCF of gas per month respectively.
EGPI/Firecreek, Inc. and Success Oil Co., Inc. are moving ahead with the provisions set forth in the MOU and expect to close within 30 to 60 days.
Dennis Alexander, the Company's Chairman and CFO, stated, "We are excited about the potential asset acquisition for the J.B. Tubb interests and corresponding work programs in the Crawar Field with Success Oil Co. as both operator and part owner. We believe the proposed acquisition presents a strong opportunity to address our continued efforts to build on asset accumulation, oil and gas revenues and cash flow." Additionally, Success Oil Company is presently reviewing a West Texas based oil and gas property which currently produces $106,000 net cash flow per month and has an additional 46 drilling locations for new wells to potentially be acquired by EGPI Firecreek, Inc.
EGPI Firecreek, Inc. continues review for potential leases, interests and opportunities which are located throughout the U.S. and its surrounding regions. The Company is working on various financial opportunities for the funding of potential project acquisitions and the respective capital expenditure requirements for each.
----------------------------------------------------------
Chat real-time with other investors about this BSLM news release, by
clicking this link: http://www.stockwire.com/BSLM
To view in-depth research, click the following link:
http://www.stockwire.com/detailed/analysis.php?company=BSLM
Bio Solutions Mfg Inc (OTC BB: BSLM)
Bio Solutions Manufacturing Settles Lawsuit with Bio-Solutions Franchise Corp. and Others Bio Solutions Manufacturing Retracts Press Release Allegations Dated August 23, 2007
LAS VEGAS, Oct 24, 2007 Bio Solutions Manufacturing, Inc. and Bio-Solutions Franchise Corp., or BSFC, announced today that they have settled a pending action against each other and other parties in the United States District Court for the Southern District of Mississippi. In June 2007, suit was commenced in the District Court. Since the litigation commenced, the parties have provided credible evidence to dispute the charges made against each other. The parties have reached a settlement of the litigation, which will be globally dismissed with prejudice. As part of the settlement, the parties acknowledge that the allegations in the filings with the District Court are withdrawn and are hereby expressly publicly retracted, including specifically the allegations made in the press release issued by Bio Solutions Manufacturing on August 23, 2007, at 5:02 a.m. EST, alleging breach of fiduciary duty, usurpation of corporate opportunity, federal and state securities fraud, misappropriation of trade secrets, conversion, unlawful distribution of securities, interference with contractual relations and prospective business advantage, unfair competition and business practices, breach of contract, breach of the covenant of good faith and fair dealing, civil conspiracy, fraud, and misrepresentation, self-dealing and wasteful transactions. All allegations of improper conduct attributable to Bio-Solutions Franchise Corporation, N. Wayne Wade, Louis H. Elwell, III, Innovative Industries, LLC, Bio-Solutions of Louisiana, LLC, Environmental Services of Mississippi, LLC, Wade's Farm, LLC, Sabrina Baio and Amanda Best, are hereby likewise expressly completely publicly retracted.
BSLM no longer makes these contentions, and is pleased that it is able to retract the allegations made in the filings with the U.S. District Court. BSLM is also pleased that BSFC has likewise withdrawn its contentions and retracted the allegations against BSLM in the U.S. District Court.
BSLM wishes to acknowledge the efforts and cooperation of BSFC in bringing this case to a conclusion. BSLM believes that this resolution is in the best interest of all parties. BSLM wishes to acknowledge the contributions of the BSFC group to BSLM over the years, and thanks them for those contributions.
About Bio Solutions Manufacturing, Inc.
Bio Solutions Manufacturing has developed microbiological products for waste bioremediation. The Company's products are currently used by many municipal collection systems and food service facilities in the United States. The Company's products have been approved by municipalities for use in food service facilities that produce waste products introduced into the municipal collection systems. The Company's products treat waste in an environmentally friendly and safe manner in compliance with Federal and State government standards.
The Company has developed a line of environmentally friendly cleaning products that include all-purpose cleaner, carpet cleaner, concrete and asphalt cleaner, and floor soap. In addition, the Company is developing a unique, patent-pending grease extractor to be used in conjunction with bioremediation solutions to extract desired oil and grease to be converted into value-added product, such as biodiesel fuel.
----------------------------------------------------------
Chat real-time with other investors about this RBRM news release, by
clicking this link: http://www.stockwire.com/RBRM
To view in-depth research, click the following link:
http://www.stockwire.com/detailed/analysis.php?company=RBRM
Rebuilder Med Tech Inc (Pink Sheet: RBRM)
ReBuilder Medical Technologies, Inc. Celebrates Five Years and 50,000th Shipment
CHARLES TOWN, W.Va., Oct 23, 2007 After five successful years of steady growth, ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM) announced today that it is celebrating five years of continued operations by shipping out its 50,000th order, and sales growth that indicates reaching 100,000 orders by the end of 2008. "Our ReBuilder for Diabetic Peripheral Neuropathy has been a steady winner for us. Today we celebrate our 50,000th shipment. Some of these orders were for the ReBuilder electronic device, some were for the consumable support products that the patients consume, and others were for the Phillips Molluscum Treatment System(TM) and its consumables. The ReBuilder System(R) itself can stand alone, and produces 100% profit margins, however, we have offered accessories and refills on its consumables and all together, with the new customers and the returning customers who re-order their supplies, we are happy to have reached this milestone," says David B. Phillips, Ph.D. CEO of ReBuilder Medical Technologies, Inc.
"Our sales have been growing regularly and as a result of about 33% of our sales coming from referrals from happy customers, and the new marketing partners, we hope to ship an additional 50,000 orders, in the next year, and have geared production, inventory control, and general management practices accordingly. It takes new practices to cope with the sales and customer service any company is accustomed to," said David B. Phillips, Company CEO, at the end of this interview. The anticipated 50,000 shipments should take us to the next level in mass marketing.
About ReBuilder Medical Technologies, Inc.: ReBuilder Medical Technologies, Inc. is a manufacturer of medical devices and innovative technologies founded by world-renowned medical device inventor David B. Phillips, Ph.D. The company's flagship product is its FDA registered ReBuilder System(R), used for treating peripheral neuropathy. Unlike current therapies for neuropathy (nerve disease) that depend on prescription drugs with powerful side effects, the ReBuilder System(R) is a portable, battery-powered medical product that provides a unique, non-surgical treatment which is non-invasive, has no side effects and can actually strengthen muscles while increasing blood flow.
ReBuilder Medical Technologies, Inc. also manufactures the Phillips Molluscum Treatment System(TM) for treating the skin disease Molluscum Contagiosum which primarily affects children. This system uses its proprietary form of micronized amorphous silver ions to disable the molluscum pathogen without side effects. The company is currently performing research and development on a number of other products as well.
ReBuilder Medical Technologies, Inc. is located in Charles Town, WV. CEO, Dr. David Phillips, Ph.D. is best known for inventing the very first infrared ear thermometer. Dr. Phillips also was responsible for the GST System, which is used for the early detection of breast cancer, and the AcuPen, a hand-held device that provides the benefits of acupuncture without the use of needles.
----------------------------------------------------------
As a trader, a very intelligent place to put your money, is where the money is flowing into. These are the kind of trades that you want to get into.
As the saying goes...follow the money!
To see the complete Movers & Shakers Blog go to: http://www.stockwire.com .
About Stockwire:
Stockwire is a company that is pioneering a new way to research companies before you invest them. It's called a Stockumentary. A Stockumentary is a documentary on a publicly traded company. Imagine a Dateline NBC segment, but on a publicly traded company. We are the first company to ever bring this type of quality research to investors in this format.
The Stockumentary has video interviews with management, product demos, video tours of office or factory, research reports, sec filings and much more. All of this is delivered to investors in high quality video, either by mail or email.
Stockwire.com is owned by Stockwire Research Group Inc. (SRGI) and is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies.
As detailed below, this publication accepts compensation from some of the companies from which it features. To the degrees listed herein, this Newsletter should not be regarded as an independent publication. All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the Newsletter is neither an offer nor solicitation to buy or sell any securities mentioned.
While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF STOCKWIRE RESEARCH GROUP INC..
We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at www.sec.gov and/or the National Association of Securities Dealers ("NASD") at www.nasd.com. The NASD has published information on how to invest carefully at its web site.
Readers can review all public filings by companies at the SEC's EDGAR page. www.sec.gov/edgar.shtml
Stockwire.com is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. Stockwire.com is not a registered investment advisor or broker-dealer. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible.
From time to time SRGI sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.
Moreover, as detailed below, this publication accepts compensation from third party consultants and/or companies which it features on Stockwire.com, which is owned by Stockwire Research Group Inc. (SRGI). To the degrees enumerated herein, this newsletter and website should not be regarded as an independent publication.
All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company on Stockwire.com is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF STOCKWIRE.COM.
We often accept restricted shares of company stock; by SEC regulations, restricted shares cannot be sold into the market for a period of at least one year from the time that the shares are issued. In such cases, we detail in the Disclaimer the specific term of any restrictions. We also receive compensation in the form of stock options, in which case we receive the right to buy shares of the stock of the company at issue, at a specified time and a specified price. In such circumstances, we specify on our Disclaimer the terms of the options received. On occasion, we also accept free-trading shares in a company that we cover. We intend to sell these shares at any given time.
While our policies as detailed above are designed to minimize any impact upon our members of a conflict of interest between our company and our members, each member should be fully aware that such potential and actual conflicts of interest may well exist due to the compensation structure detailed herein. For this reason, and because the information contained on Stockwire.com is updated on a regular basis as circumstances change, each member is strongly encouraged to periodically review the Profile Compensation section at http://www.stockwire.com/disclaimer_profiles.htm .
The Stockwire Group .
512.358.8440 .
info@stockwire.com .
